- GlobeNewswire•last month
NEW YORK, Sept. 23, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September ...
- GlobeNewswire•2 months ago
NEW YORK, Sept. 07, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Rodman & Renshaw 18 th Annual Global Investment conference on Monday, ...
Stemline Therapeutics, Inc. (STML)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||6.50 x 100|
|Ask||19.19 x 100|
|Day's Range||11.85 - 12.25|
|52wk Range||3.88 - 14.20|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.60|
|Avg Vol (3m)||177,948|
|Dividend & Yield||N/A (N/A)|